Diabetes mellitus, type 2 / drug therapyRefine your research by the most used items
Author / Editor
- Agoritsas, Thomas (1)
- Beran, David Henri (1)
- Cartwright, Emma Jane (1)
- Daux, Aurélien (1)
- Ferns, Linda (1)
- Foroutan, Farid (1)
- Frere, Lawrie (1)
- Gariani, Karim (1)
- Gee, Patrick (1)
- Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC) (1)
Document type
Full text accessibility
Full text version
Subject
- Humans (5)
- Sodium-glucose transporter 2 inhibitors / therapeutic use (3)
- Diabete de type 2 (2)
- Diabetes mellitus, type 2 / epidemiology (2)
- Glucagon-like peptide-1 receptor / agonists (2)
- Hypoglycemic agents / adverse effects (2)
- Insulin / therapeutic use (2)
- Adult (1)
- Africa south of the sahara / epidemiology (1)
- Amputation, surgical (1)
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Considérations pratiques pour l’utilisation des inhibiteurs du SGLT2 dans les maladies cardiovasculaires | Lu, Henri; Hullin, Roger; Yerly, Patrick; Meyer, Philippe; ... Daux, Aurélien | 2021 |
|
|
Diabetes care in sub-Saharan Africa | Beran, David Henri; Yudkin, John S | 2006 |
|
|
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis | Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC) | 2021 |
|
|
Inhibiteurs du SGLT2 : que des bénéfices? | Sciotto, Lucie; Jornayvaz, François | 2021 |
|
|
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline | Li, Sheyu; Vandvik, Per Olav; Lytvyn, Lyubov; Guyatt, Gordon H; ... Mustafa, Reem A | 2021 |
